Weidong M. Kong - Publications

Revisiting the rationale for radical resection in low-risk early rectal cancer: a population-level perspective.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: October 01, 2025

Fragmentation of Multimodal Rectal Cancer Care: A Population-Level Retrospective Cohort Study.

Journal: Journal of surgical oncology

Published: February 15, 2025

2024 Canadian Surgery Forum: Sept. 25-28, 2024.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: November 28, 2024

Factors Influencing the Timeliness and Completeness of Appropriate Staging Investigations for Patients with Stage I-III Lung Cancer in Southeastern Ontario.

Journal: Current oncology (Toronto, Ont.)

Published: August 15, 2024

Local excision for T1 rectal cancer: A population-based study of practice patterns and oncological outcomes.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: May 25, 2024

An assessment of cancer centre level designation and guideline adherent care in those with rectal cancer: A population based retrospective cohort study.

Journal: Journal of cancer policy

Published: May 07, 2024

2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Journal: Canadian journal of surgery. Journal canadien de chirurgie

Published: January 04, 2024

The management of stage I Non-Small cell lung cancer (NSCLC) in Ontario: A Population-Based study of patterns of care and Stereotactic Ablative Body radiotherapy (SABR) utilization from 2010 to 2019.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 16, 2023

Real-world outcomes associated with bevacizumab combined with chemotherapy in platinum-resistant ovarian Cancer.

Journal: Gynecologic oncology

Published: October 20, 2023

Characterizing Variability in Lung Cancer Outcomes and Influence of a Lung Diagnostic Assessment Program in Southeastern Ontario, Canada.

Journal: Current oncology (Toronto, Ont.)

Published: February 28, 2023

Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer.

Journal: Journal of cancer policy

Published: January 09, 2023

Explaining regional variations in colon cancer survival in Ontario, Canada: a population-based retrospective cohort study.

Journal: BMJ open

Published: September 19, 2022